Aesthetic manufacturers can now receive consulting and advice for hyaluronic acid and chitosan products with the launch of Falgagen.
The company explains that it serves the life sciences industries in the conception and development of the medical devices comprising the aforementioned ingredients.
Falgagen states that the team is composed of scientists and medical device strategists and is committed to providing their partners with customised services in research and development, innovation, formulation, industrial operations and business development.
Thomas Fevre, managing partner and co-founder of Falgagen said, “We are at the forefront of a new era in the medical device industry. Any market player involved in the marketing of hyaluronic acid or chitosan-based products will have to embrace a much larger regulatory responsibility and will have to quickly master technical competences on these molecules to continue innovating. We are here to support them integrating efficiently advance experiences and competences.”